These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 38836286)
21. Immuno-PET imaging of Liu Q; Jiang L; Li K; Li H; Lv G; Lin J; Qiu L Cancer Immunol Immunother; 2021 Jun; 70(6):1721-1733. PubMed ID: 33386467 [TBL] [Abstract][Full Text] [Related]
22. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer. Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging. Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184 [TBL] [Abstract][Full Text] [Related]
24. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
25. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules. Rinne SS; Dahlsson Leitao C; Saleh-Nihad Z; Mitran B; Tolmachev V; Ståhl S; Löfblom J; Orlova A Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183096 [TBL] [Abstract][Full Text] [Related]
26. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329 [TBL] [Abstract][Full Text] [Related]
27. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
28. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1. Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025 [TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Characterization of an Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and Preclinical Evaluation of a Li H; Yuan L; Long Y; Fang H; Li M; Liu Q; Xia X; Qin C; Zhang Y; Lan X; Gai Y Mol Pharm; 2020 Aug; 17(8):3000-3008. PubMed ID: 32544337 [TBL] [Abstract][Full Text] [Related]
31. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Al Gai Y; Yuan L; Sun L; Li H; Li M; Fang H; Altine B; Liu Q; Zhang Y; Zeng D; Lan X J Biol Inorg Chem; 2020 Feb; 25(1):99-108. PubMed ID: 31745667 [TBL] [Abstract][Full Text] [Related]
33. Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma. Yuan P; Long Y; Wei N; Wang Y; Zhu Z; Han J; Jiang D; Lan X; Gai Y J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39043603 [TBL] [Abstract][Full Text] [Related]
34. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595 [TBL] [Abstract][Full Text] [Related]
35. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931 [TBL] [Abstract][Full Text] [Related]
36. A Novel Small Cyclic Peptide-Based Liu H; Hu M; Deng J; Zhao Y; Peng D; Feng Y; Wang L; Chen Y; Qiu L Mol Pharm; 2022 Jan; 19(1):138-147. PubMed ID: 34910492 [TBL] [Abstract][Full Text] [Related]
37. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments. Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837 [TBL] [Abstract][Full Text] [Related]
38. [ Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071 [TBL] [Abstract][Full Text] [Related]
39. Targeting CAIX with [ Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors. Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]